Skip to content

Innovation of surgical strategies and evaluation of clinical outcomes of robot-assisted total knee arthroplasty

Innovation of surgical strategies and evaluation of clinical outcomes of robot-assisted total knee arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099579
Enrollment
Unknown
Registered
2025-03-26
Start date
2025-03-26
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Experimental group:Total knee arthroplasty using the TiRobot Orthopedic Surgical System
Control group:Surgery using standard total knee arthroplasty instruments

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 - 80, any gender; 2) Knee osteoarthritis patients unresponsive to conservative treatment; 3) Patients assessed by researchers as needing first-time unilateral total knee arthroplasty; 4) Participants fully aware of the study's benefits and risks, and sign the consent form.

Exclusion criteria

Exclusion criteria: Participants in this clinical study must not meet any of the following criteria: 1.BMI>35kg/m^2; 2.Patients with heart,lung,or other vital organ failure; 3.Abnormal liver/kidney function(ALT/AST>1.5×normal,BUN>8.3mmol/L,Scr>115µmol/L); 4.Diabetic patients with poor glycemic control and infection risk per investigator's judgment; 5.Disorders of consciousness or mental illness; 6.History of open knee surgery; 7.Neuromuscular disorders affecting lower limb function; 8.Severe coagulation disorders; 9.Severe internal/surgical diseases or frailty making surgery intolerable; 10.Severe instability not curable by ligament - retaining TKA; 11.Active infection foci(systemic or local); 12.Severe osteoporosis,metabolic bone disease,radiation - induced bone disease,tumor around the knee; 13.Women planning pregnancy,breast - feeding,or pregnant during the study; 14.Participation in other clinical studies within 3 months; 15.Deemed unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Alignment restoration accuracy;

Secondary

MeasureTime frame
Prosthesis implantation precision;Joint function assessment;Surgical time;Total blood loss;Overall machine functionality, stability, and ease-of-use assessment;

Countries

China

Contacts

Public ContactGuoqiang Zhang

Chinese PLA General Hospital

jfysxmu@163.com+86 136 0121 0743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026